Debiopharm, Oncodesign Services announce license agreement for use of AbYlink technology for pre-clinical services

… is a regio-selective bioconjugation technology ideally suited for preparing conjugates … use of the non-invasive technology in Radioimmunotherapy, targeting animal models … rapid regio-selective chemical conjugation technology for use to prepare diagnostic …

Scroll to Top